Biden’s Buy-American Pledge Could Hurt Generic Drug Industry

By Ariel Cohen / November 19, 2020 at 2:25 PM
Updated Story President-elect Joe Biden’s pledge that his administration will only contract with companies that make products domestically ​could negatively impact generic drug makers, but the incoming Biden administration's policy generally is not expected to affect coronavirus drugs and vaccines because nearly all of the contracts signed by the Trump administration are for products that already are made in the United States. “From autos to our stockpiles, we’re going to buy American. No government contracts will be...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.